Skip to main content

Table 7 Pregnancy outcome after embryo transfer by absolute value of AMH according to patient age

From: Age-specific definition of low anti-Mullerian hormone and associated pregnancy outcome in women undergoing IVF treatment

  Age of patients < 35 P value
Embryo transfer with AMH ≥ 1.0 ng/ml (n = 576) Embryo transfer with AMH < 1.0 ng/ml (n = 38)
Positive hCG per transfer 62.5% (360/576) 42.1% (16/38) 0.012
Positive hCG per D3 embryo transfer 62.5% (283/453) 35.5% (15/36) 0.014
Positive hCG per blastocyst transfer 62.6% (77/123) 50% (1/2) 1.00
Biochemical pregnancy per transfer 4.9% (28/576) 2.6% (1/38) 1.00
Ectopic pregnancy per transfer 0.9% (5/576) 0 1.00
Clinical pregnancy per transfer 56.8% (327/576) 39.5% (15/38) 0.038
Miscarriage per clinical pregnancy 9.2% (30/327) 20% (3/15) 0.167
Ongoing pregnancy per transfer 51.6% (297/576) 31.6% (12/38) 0.017
Ongoing pregnancy per D3 embryo transfer 50.8% (230/453) 30.6% (11/36) 0.02
Ongoing pregnancy per blastocyst transfer 54.5% (67/123) 50% (1/2) 1.00
  Age of patients≥35  
Embryo transfer with AMH ≥ 1.0 ng/ml (n = 326) Embryo transfer with AMH < 1.0 ng/ml (n = 68)
Positive hCG per transfer 49.1% (160/326) 26.5% (18/68) 0.001
Positive hCG per D3 embryo transfer 46.5% (119/256) 27.7% (18/65) 0.006
Positive hCG per blastocyst transfer 58.6% (41/70) 0 (0/3) 0.08
Biochemical pregnancy per transfer 4.3% (14/326) 4.4% (3/68) 1.00
Clinical pregnancy per transfer 44.8% (146/326) 22.1% (15/68) 0.001
Miscarriage per clinical pregnancy 17.1% (25/146) 26.7% (4/15) 0.573
Ongoing pregnancy per transfer 34.1% (121/326) 16.2% (11/68) 0.001
Ongoing pregnancy per D3 embryo transfer 34.0% (87/256) 16.9% (11/65) 0.008
Ongoing pregnancy per blastocyst transfer 48.6% (34/70) 0 (0/3) 0.243